T1DM

Clinical trials for T1DM explained in plain language.

Never miss a new study

Get alerted when new T1DM trials appear

Sign up with your email to follow new studies for T1DM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New drug aims to control type 1 diabetes early

Disease control Recruiting now

This study tests a new medicine called CNP-103 in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease by calming the immune system. Participants will receive either …

Matched conditions: T1DM

Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control

Last updated May 04, 2026 16:30 UTC

T1DM

Get alerted when new T1DM trials appear

New drug aims to control type 1 diabetes early